Pharvaris N.V. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on June 11, 2024, by Pharvaris N.V., a foreign private issuer based in Leiden, The Netherlands, serves to disseminate materials related to the Company's 2024 Annual General Meeting of Shareholders scheduled for June 28, 2024. The filing incorporates by reference the Annual Report for the fiscal year ended December 31, 2023.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached Annual Report (Exhibit 99.4) but are not summarized in the body of this Form 6-K.
Material Changes
No material financial changes or operational updates are detailed in the text of this filing. The document functions primarily as a notice of the upcoming shareholder meeting and a vehicle for distributing the 2023 Annual Report.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, or specific risk disclosures. It references the convening notice and voting proxy materials (Exhibits 99.2 and 99.3) which may contain agenda items relevant to shareholder decisions.
Key Facts for Investor Verification
- Verify the date and agenda of the 2024 Annual General Meeting (June 28, 2024) via the attached Convening Notice (Exhibit 99.2).
- Review the full 2023 Annual Report (Exhibit 99.4) for detailed financial performance, as this Form 6-K does not summarize the numbers.
- Confirm the voting procedures and proxy instructions outlined in Exhibit 99.3.
- Note that the filing is signed by Berndt Modig, Chief Executive Officer.